1. 国家自然科学基金面上项目，81371451，具有NMDA受体NR2B选择性拮抗活性的依达拉奉衍生物的发现，2014.01-2017.12，70万元，已结题。

2. 江苏省自然科学基金面上项目，BK20131390，新型依达拉奉-NMDA受体NR2B选择性拮抗剂孪药的设计、合成及生物活性研究，2013/07-2016/06，10万元，已结题。

3. 江苏省自然科学基金面上项目，BK2010538，新型多重作用机制抗脑卒中神经保护剂的发现，2010/06-2012/12，10万元，已结题。

1.LiYi Chen; ChuanZhou Yang; Yi Xu; ChangYong Qi; Yan Zhong*; Bin Wu*.Synthesisi, crystal structure and biological evaluation of (E)-1-(4-(4-bromobenzyl)piperazin-1-yl)-3-(4-chlorophenyl)-prop-2-en-1-one, Journal of Structural Chemistry, 2021, 62(3):511-520.

2.Yan Zhong; Yarong Gao; Yi Xu; Changyong Qi; Bin Wu. Synthesis of novelaryloxyethylamine derivatives and evaluation of their in vitro and in vivoneuroprotective activities, Chemistry & Biodiversity, 2020,17(9): e2000431.

3.Jiangang Zhong; Jiapei Han; Xiaofeng Li; Yi Xu; Yan Zhong*; Bin Wu*.Synthesis, crystal structure, Hirshfeld surfaces analysis and anti-ischemicactivity of cinnamide derivatives, Journal of Molecular Structure, 2018,1154(1): 72-78.

4.Yan Zhong; Xiaofeng Li; Aixia Zhang; Yi Xu; Ping Li; Bin Wu*.Design, synthesis and neuroprotective activities of novel cinnamide derivativescontaining benzylpiperazine moiety, Medicinal Chemistry Research,2018, 27(5): 1366-1373.

5.Yan Zhong; Yi Xu; Aixia Zhang; Xiaofeng Li; Zhaoying Xu; Ping Li; Bin Wu^*.Synthesis and biological evaluation of aryloxyacetamide derivatives asneuroprotective agents, Bioorganic & Med icinal Chemistry Letters, 2016,26(10): 2526-2530.